191 related articles for article (PubMed ID: 26502694)
1. Type 1 reaction masquerading clinically as ENL: A Case Report.
Khodke A; Shetty VP
Lepr Rev; 2015 Jun; 86(2):202-5. PubMed ID: 26502694
[TBL] [Abstract][Full Text] [Related]
2. International workshop on erythema nodosum leprosum (ENL)--consensus report; the formation of ENLIST, the ENL international study group.
Walker SL; Saunderson P; Kahawita IP; Lockwood DN
Lepr Rev; 2012 Dec; 83(4):396-407. PubMed ID: 23614260
[No Abstract] [Full Text] [Related]
3. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
Savitha B; Sardana K; Kumari R; Khurana A; Sinha S; Sachdeva S
Am J Trop Med Hyg; 2021 Oct; 106(1):51-53. PubMed ID: 34662871
[TBL] [Abstract][Full Text] [Related]
4. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
Verma KK; Srivastava P; Minz A; Verma K
Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic challenge.
Kawakami T; Tsutsumi Y; Mizoguchi M; Ishi N; Soma Y
Int J Dermatol; 2007 Apr; 46(4):348-9. PubMed ID: 17442070
[No Abstract] [Full Text] [Related]
7. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
8. [Bullous erythema nodosum leprosum. A case report in French Guiana].
Couppié P; Sainte-Marie D; About V; Heid E; Pradinaud R
Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
10. Bullous erythema nodosum leprosum manifesting in the post partum period with unusual features.
Verma R; Vasudevan B; Pragasam V; Moorchung N; Mitra D; Gopal M
Lepr Rev; 2015 Mar; 86(1):96-101. PubMed ID: 26065152
[TBL] [Abstract][Full Text] [Related]
11. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
12. Lepromatous leprosy in Saudi female from central region.
al-Majed S
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
Upputuri B; Pallapati MS; Tarwater P; Srikantam A
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
[TBL] [Abstract][Full Text] [Related]
14. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous lepromas as leprosy-type presentation.
Alvarez-Ruiz SB; Delgado-Jiménez Y; Aragüés M; Fraga J; García-Díez A
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):344-5. PubMed ID: 16503904
[No Abstract] [Full Text] [Related]
17. Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity.
Martiniuk F; Giovinazzo J; Tan AU; Shahidullah R; Haslett P; Kaplan G; Levis WR
J Drugs Dermatol; 2012 May; 11(5):626-30. PubMed ID: 22527432
[TBL] [Abstract][Full Text] [Related]
18. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
Hebe Petiti-Martin G; Villar-Buill M; de la Hera I; Fuertes L; Burgués-Calderón M; Rivera-Díaz R; Vanaclocha F
Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
[TBL] [Abstract][Full Text] [Related]
19. Elevated Pentraxin-3 Concentrations in Patients With Leprosy: Potential Biomarker of Erythema Nodosum Leprosum.
Mendes MA; de Carvalho DS; Amadeu TP; Silva BJA; Prata RBDS; da Silva CO; Ferreira H; Hacker MA; Nery JAC; Pinheiro RO; Sampaio EP; Sarno EN; Schmitz V
J Infect Dis; 2017 Dec; 216(12):1635-1643. PubMed ID: 29272525
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide levels in patients with erythema nodosum leprosum.
Vieira JL; Valente Mdo S
Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]